Accelerant Holdings Ltd Class A Ordinary Shares (ARX)
Is the Options Market Predicting a Spike in Accelerant Stock?
Investors need to pay close attention to ARX stock based on the movements in the options market lately.
Accelerant's Take-Private Deal Raises a Bigger Question for Insurance Stocks
Accelerant Holdings NYSE: ARX jumped into view for investors in mid-August after its shares surged 43% in a single day. This type of share price leap is often reserved for clinical-stage biotech firms announcing breakthrough results, for instance, not for an unglamorous firm connecting specialty insurance risk across a network of capital providers.
After Golden Cross, Accelerant Holdings (ARX)'s Technical Outlook is Bright
Accelerant Holdings (ARX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ARX's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Why Is Accelerant Going Private Just One Year After Its IPO?
ARX is going private just over a year after its IPO, as Thoma Bravo's $4 billion deal capitalizes on stronger operating results.
Accelerant Q2 Earnings Beat Estimates on Strong Premium Growth
ARX's Q2 earnings beat estimates as premium growth, higher fee revenues and stronger Exchange Services drive results.
Accelerant Holdings (ARX) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Accelerant Holdings (ARX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Accelerant Holdings (ARX) Tops Q2 Earnings and Revenue Estimates
Accelerant Holdings (ARX) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.14 per share a year ago.
Will Lower Underwriting Profit Hurt Accelerant Holdings' Q2 Results?
ARX's Q2 results may face pressure from weaker Underwriting and MGA profitability despite strong premium and investment income growth.
Accelerant Holdings (ARX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Accelerant Holdings (ARX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in Accelerant Holdings (ARX): Can Its 6.1% Jump Turn into More Strength?
Accelerant Holdings (ARX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Accelerant Advances Fee-Based Model With WoodStar Partnership
ARX partners with WoodStar to add $220M+ in underwriting capacity, advancing its fee-based model and expanding insurance growth opportunities.
Wall Street Analysts Think Accelerant Holdings (ARX) Could Surge 39.43%: Read This Before Placing a Bet
The mean of analysts' price targets for Accelerant Holdings (ARX) points to a 39.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
